LidoPatch Pain Relief Patches Recalled Due to Missing Manufacturing Records
Wuhan Bingbing Pharmaceutical is recalling LidoPatch pain relief patches because missing manufacturing records prevent verification that the product remains within specification through its expiration date.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II due to CGMP deviations involving missing records, which is a documentation and quality assurance issue rather than a confirmed contamination or injury event, fitting the 'Moderate' criteria for minor labeling/documentation errors or low-risk issues.
Plain-English summary
Wuhan Bingbing Pharmaceutical Co., Ltd. is recalling LidoPatch (lidocaine HCl 3.6%, menthol 1.25%) Pain Relief Patches. The recall involves 4,960 boxes of the product, which was distributed nationwide in the USA. The affected product is manufactured for JAR Laboratories, Elmhurst, IL, and includes specific batch numbers with expiration dates ranging from January 2021 to January 2022.
The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations. Specifically, the manufacturer lost product manufacturing records and retained product samples. As a result, there is no assurance that the product will remain within specification through the labeled expiration date.
Consumers who have purchased these specific batches of LidoPatch should stop using the product and contact the recalling firm or their healthcare provider for further instructions. The FDA has classified this recall as Class II, indicating a reasonable probability that use of the product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- LidoPatch (lidocaine HCl 3.6%, menthol 1.25%) Pain Relief Patch, packaged in 1 patch/box (NDC 10882-527-01); 30 patches/box (NDC 10882-527-02 and 10882-527-04), Manufactured for: JAR Laboratories, Elmhurst, IL.
- Manufacturer
- Wuhan Bingbing Pharmaceutical Co., Ltd.
- Category
- Drug — Topical Analgesic
- Affected units
- 4,960
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- Batch #: 1180103
- Exp 2021.01.02
- 180104
- Exp 2021.01.03
- 80105
- Exp 2021.01.04
- 180106
- Exp 2021.01.05
- 80107
- Exp 2021.01.06.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 4 recalled by Wuhan Bingbing Pharmaceutical Co., Ltd. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · Wuhan Bingbing Pharmaceutical Co., Ltd.
See all →- ModerateMencaine Lidocaine Patches Recalled Due to Missing Manufacturing Records
FDA (Drugs) · 2020-06-03
- ModerateLidoPro Patches Recalled Due to Missing Manufacturing Records
FDA (Drugs) · 2020-06-03
- ModerateCVS Lidocaine Cold and Hot Patch Recalled for Manufacturing Record Loss
FDA (Drugs) · 2020-06-03
Same hazard · documentation error
See all →- ModerateHenry Schein Recalls Structur 2 SC Temporary Resin Cartridges for Incorrect Packaging
FDA (Devices) · 2026-09-02
- ModerateConMed Suture Anchor Recalled for Incorrect Patient Implant Card
FDA (Devices) · 2026-09-02
- ModeratePower Over Fiber Base Modules Recalled Due to Incorrect Laser Classification and Labeling
FDA (Devices) · 2026-08-05
- ModerateEmbrace standard drill tower surgical technique lists mixed-up article numbers
FDA (Devices) · 2026-04-01
- ModerateEmbrace shoulder drill tower surgical technique lists mixed-up article numbers
FDA (Devices) · 2026-04-01